# PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED

> **NCT05142332** · NA · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 541 (actual)

## Conditions studied

- Covid-19 Vaccine
- Vaccine Hesitancy

## Interventions

- **OTHER:** Covid-19 vaccine education materials

## Key facts

- **NCT ID:** NCT05142332
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-12-06
- **Primary completion:** 2022-07-28
- **Final completion:** 2022-08-30
- **Target enrollment:** 541 (ACTUAL)
- **Why stopped:** met interim analysis criteria for early termination
- **Last updated:** 2023-12-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05142332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05142332, "PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05142332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*